What is an appropriate strategy of conversion surgery for cT4b thoracic esophageal cancer?
作者信息
Ozawa Soji
机构信息
Department of Gastroenterological Surgery Tokai University School of Medicine Isehara Japan.
出版信息
Ann Gastroenterol Surg. 2021 Apr 9;5(2):130-131. doi: 10.1002/ags3.12453. eCollection 2021 Mar.
Abstract
摘要
相似文献
1
What is an appropriate strategy of conversion surgery for cT4b thoracic esophageal cancer?对于cT4b期胸段食管癌，合适的转化手术策略是什么？
Ann Gastroenterol Surg. 2021 Apr 9;5(2):130-131. doi: 10.1002/ags3.12453. eCollection 2021 Mar.
2
Strategy Treatment of cT4b Esophageal Squamous Cell Carcinoma Using Docetaxel, Cisplatin, and 5-Fluorouracil.多西他赛、顺铂和氟尿嘧啶治疗 cT4b 食管鳞癌的策略。
Anticancer Res. 2022 Jul;42(7):3725-3733. doi: 10.21873/anticanres.15862.
3
Clinical Implications of Conversion Surgery After Induction Therapy for T4b Thoracic Esophageal Squamous Cell Carcinoma.诱导治疗后 T4b 期胸段食管鳞癌行转换手术后的临床意义。
Ann Surg Oncol. 2019 Dec;26(13):4737-4743. doi: 10.1245/s10434-019-07727-8. Epub 2019 Aug 14.
4
Long-term survival and prognostic factors associated with curative conversion surgery for ct4b esophageal squamous cell carcinoma: Analysis of 200 consecutive cases.根治性转换手术治疗 ct4b 期食管鳞癌的长期生存及预后因素分析：200 例连续病例分析。
Surgery. 2023 Sep;174(3):558-566. doi: 10.1016/j.surg.2023.05.040. Epub 2023 Jun 28.
5
Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma.cT4b 期食管癌患者行扩大放化疗加手术的可行性。
Eur J Surg Oncol. 2020 Apr;46(4 Pt A):626-631. doi: 10.1016/j.ejso.2019.10.023. Epub 2019 Oct 21.
6
Advantageous factors of R0 curative conversion esophagectomy and the optimal extent of lymphadenectomy after induction therapy for cT4b thoracic esophageal cancer.cT4b期胸段食管癌诱导治疗后R0根治性转化食管切除术的有利因素及最佳淋巴结清扫范围
Ann Gastroenterol Surg. 2020 Dec 11;5(2):204-214. doi: 10.1002/ags3.12416. eCollection 2021 Mar.
7
Treatment patterns and survival in advanced unresectable esophageal squamous cell cancer: A population-based study.晚期不可切除食管鳞癌的治疗模式和生存：一项基于人群的研究。
Cancer Sci. 2022 Mar;113(3):1038-1046. doi: 10.1111/cas.15262. Epub 2022 Jan 25.
8
Conversion Surgery in cT4B Esophageal Cancer: Myth or Reality?cT4B期食管癌的转化手术：神话还是现实？
Ann Surg Oncol. 2024 Oct;31(10):6354-6356. doi: 10.1245/s10434-024-15608-y. Epub 2024 Jun 11.
9
Definitive chemoradiotherapy for clinical T4b esophageal cancer - Treatment outcomes, failure patterns, and prognostic factors.临床 T4b 期食管癌的确定性放化疗 - 治疗结果、失败模式和预后因素。
Radiother Oncol. 2021 Apr;157:56-62. doi: 10.1016/j.radonc.2021.01.007. Epub 2021 Jan 19.
10
Endobronchial Ultrasonography to Assess and Evaluate Tracheobronchial Tree Invasion in cT4b Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy: Assessment of Resectability.经支气管超声检查评估和评价接受根治性放化疗的cT4b期食管癌患者气管支气管树侵犯情况：可切除性评估
Ann Surg Oncol. 2025 Jan;32(1):284-292. doi: 10.1245/s10434-024-15621-1. Epub 2024 Jul 6.
引用本文的文献
1
Robot-Assisted Minimally Invasive Esophagectomy: Current Best Practice.机器人辅助微创食管切除术：当前最佳实践
Dig Surg. 2025 Jun 5:1-9. doi: 10.1159/000546749.
本文引用的文献
1
Advantageous factors of R0 curative conversion esophagectomy and the optimal extent of lymphadenectomy after induction therapy for cT4b thoracic esophageal cancer.cT4b期胸段食管癌诱导治疗后R0根治性转化食管切除术的有利因素及最佳淋巴结清扫范围
Ann Gastroenterol Surg. 2020 Dec 11;5(2):204-214. doi: 10.1002/ags3.12416. eCollection 2021 Mar.
2
Clinical Implications of Conversion Surgery After Induction Therapy for T4b Thoracic Esophageal Squamous Cell Carcinoma.诱导治疗后 T4b 期胸段食管鳞癌行转换手术后的临床意义。
Ann Surg Oncol. 2019 Dec;26(13):4737-4743. doi: 10.1245/s10434-019-07727-8. Epub 2019 Aug 14.
3
Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review.临床T4期食管癌的治疗与临床结局：一项系统评价
Ann Gastroenterol Surg. 2018 Dec 13;3(2):169-180. doi: 10.1002/ags3.12222. eCollection 2019 Mar.
4
Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2.日本食管癌学会编辑的《2017年食管癌诊疗指南》：第2部分
Esophagus. 2019 Jan;16(1):25-43. doi: 10.1007/s10388-018-0642-8. Epub 2018 Aug 31.
5
Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1.日本食管癌学会编辑的《2017年食管癌诊疗指南》：第1部分。
Esophagus. 2019 Jan;16(1):1-24. doi: 10.1007/s10388-018-0641-9. Epub 2018 Aug 31.
6
Comparison of Outcome of Esophagectomy Versus Nonsurgical Treatment for Resectable Esophageal Cancer with Clinical Complete Response to Neoadjuvant Therapy.新辅助治疗后临床完全缓解的可切除食管癌行手术与非手术治疗的结局比较。
Ann Surg Oncol. 2018 Aug;25(8):2428-2433. doi: 10.1245/s10434-018-6437-2. Epub 2018 Mar 21.
7
Japanese Classification of Esophageal Cancer, 11th Edition: part I.《日本食管癌分类第11版：第一部分》
Esophagus. 2017;14(1):1-36. doi: 10.1007/s10388-016-0551-7. Epub 2016 Nov 10.
8
Organ preservation in rectal cancer: have all questions been answered?直肠癌的保肛问题：所有问题都得到解答了吗？
Lancet Oncol. 2015 Jan;16(1):e13-22. doi: 10.1016/S1470-2045(14)70398-5. Epub 2014 Dec 29.
Zotero 插件